| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.915 | 0.002 | 0.915 | Alcohol oxidase inhibitor | 0.134 0.012 DBMET00584 | ||
| 0.871 | 0.001 | 0.871 | Alpha-N-acetylglucosaminidase inhibitor | 0.855 0.002 DBMET00584 | ||
| 0.846 | 0.004 | 0.846 | Aldehyde oxidase inhibitor | 0.179 0.117 DBMET00584 | ||
| 0.765 | 0.002 | 0.765 | Porphobilinogen synthase inhibitor | 0.066 0.06 DBMET00584 | ||
| 0.721 | 0.002 | 0.721 | GABA C receptor agonist | 0.134 0.041 DBMET00584 | ||
| 0.704 | 0.004 | 0.704 | 5 Hydroxytryptamine release inhibitor | 0.593 0.012 DBMET00584 | ||
| 0.697 | 0.004 | 0.697 | Superoxide dismutase inhibitor | |||
| 0.682 | 0.005 | 0.696 | Histamine release inhibitor | 0.696 0.005 DBMET00584 | DBMET00584 | |
| 0.67 | 0.01 | 0.832 | Cholesterol antagonist | 0.832 0.004 DBMET00584 | DBMET00584 | |
| 0.639 | 0.001 | 0.639 | Aconitate hydratase inhibitor | 0.076 0.015 DBMET00584 | ||
| 0.611 | 0.002 | 0.611 | Ferrochelatase inhibitor | 0.119 0.054 DBMET00584 | ||
| 0.595 | 0.005 | 0.595 | Peroxidase inhibitor | 0.123 0.097 DBMET00584 | ||
| 0.593 | 0.003 | 0.593 | Succinate dehydrogenase inhibitor | 0.197 0.052 DBMET00584 | ||
| 0.589 | 0.002 | 0.599 | Triose-phosphate isomerase inhibitor | 0.599 0.002 DBMET00584 | DBMET00584 | |
| 0.579 | 0.01 | 0.579 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.573 | 0.011 | 0.573 | GABA C receptor rho-3 antagonist | |||
| 0.56 | 0.003 | 0.56 | 5 Hydroxytryptamine uptake stimulant | 0.221 0.116 DBMET00584 | ||
| 0.558 | 0.002 | 0.558 | Glutamate decarboxylase inhibitor | 0.086 0.039 DBMET00584 | ||
| 0.542 | 0.015 | 0.542 | Calcium channel L-type activator | |||
| 0.515 | 0.002 | 0.515 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.492 0.003 DBMET00584 | ||
| 0.492 | 0.003 | 0.492 | Glutamate dehydrogenase inhibitor | 0.173 0.013 DBMET00584 | ||
| 0.525 | 0.043 | 0.846 | Cyclophilin D inhibitor | 0.846 0.005 DBMET00584 | DBMET00584 | |
| 0.5 | 0.028 | 0.65 | Vasodilator, peripheral | 0.65 0.01 DBMET00584 | DBMET00584 | |
| 0.475 | 0.003 | 0.597 | NADH dehydrogenase inhibitor | 0.597 0.002 DBMET00584 | DBMET00584 | |
| 0.469 | 0.003 | 0.525 | UDP-glucose 4-epimerase inhibitor | 0.525 0.002 DBMET00584 | DBMET00584 | |
| 0.462 | 0.003 | 0.462 | Histidine decarboxylase inhibitor | 0.068 0.053 DBMET00584 | ||
| 0.483 | 0.03 | 0.483 | 5 Hydroxytryptamine release stimulant | 0.437 0.038 DBMET00584 | ||
| 0.431 | 0.003 | 0.431 | Phenylalanine 4-hydroxylase inhibitor | 0.075 0.042 DBMET00584 | ||
| 0.44 | 0.012 | 0.494 | Anesthetic general | 0.494 0.008 DBMET00584 | DBMET00584 | |
| 0.426 | 0.002 | 0.426 | Biliverdin reductase inhibitor | 0.197 0.006 DBMET00584 | ||
| 0.423 | 0.004 | 0.423 | Cystathionine beta-synthase inhibitor | 0.244 0.016 DBMET00584 | ||
| 0.421 | 0.003 | 0.421 | GABA aminotransferase inhibitor | 0.218 0.004 DBMET00584 | ||
| 0.419 | 0.005 | 0.419 | Aldehyde dehydrogenase inhibitor | 0.257 0.017 DBMET00584 | ||
| 0.429 | 0.016 | 0.429 | Calcium channel activator | 0.244 0.154 DBMET00584 | ||
| 0.418 | 0.006 | 0.418 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.414 | 0.003 | 0.414 | Purinergic P2Y14 antagonist | |||
| 0.413 | 0.003 | 0.413 | Creatine kinase inhibitor | 0.117 0.044 DBMET00584 | ||
| 0.425 | 0.015 | 0.528 | Interleukin agonist | 0.528 0.007 DBMET00584 | DBMET00584 | |
| 0.417 | 0.008 | 0.417 | Protein-tyrosine phosphatase inhibitor | 0.316 0.016 DBMET00584 | ||
| 0.405 | 0.003 | 0.405 | Electrolyte absorption antagonist | |||
| 0.413 | 0.02 | 0.413 | Sigma receptor agonist | |||
| 0.43 | 0.042 | 0.784 | Antithrombotic | 0.784 0.005 DBMET00584 | DBMET00584 | |
| 0.39 | 0.003 | 0.39 | Adenylate kinase inhibitor | 0.288 0.008 DBMET00584 | ||
| 0.397 | 0.011 | 0.397 | Phospholipase C inhibitor | 0.225 0.032 DBMET00584 | ||
| 0.462 | 0.077 | 0.628 | Caspase 9 stimulant | 0.628 0.032 DBMET00584 | DBMET00584 | |
| 0.404 | 0.021 | 0.532 | DNA synthesis inhibitor | 0.532 0.011 DBMET00584 | DBMET00584 | |
| 0.397 | 0.015 | 0.397 | Dual specificity phosphatase inhibitor | |||
| 0.395 | 0.018 | 0.395 | Sodium/bile acid cotransporter inhibitor | 0.217 0.165 DBMET00584 | ||
| 0.378 | 0.004 | 0.378 | Carbonic anhydrase XV inhibitor | |||
| 0.389 | 0.015 | 0.389 | Dual specificity phosphatase 3 inhibitor | |||
| 0.435 | 0.062 | 0.655 | Antibacterial | 0.655 0.013 DBMET00584 | DBMET00584 | |
| 0.368 | 0.003 | 0.368 | Keratolytic | 0.088 0.04 DBMET00584 | ||
| 0.369 | 0.004 | 0.369 | Uric acid excretion stimulant | 0.236 0.009 DBMET00584 | ||
| 0.377 | 0.013 | 0.377 | Mcl-1 antagonist | |||
| 0.392 | 0.029 | 0.723 | Hypoglycemic | 0.723 0.005 DBMET00584 | DBMET00584 | |
| 0.367 | 0.004 | 0.367 | Alcohol dehydrogenase inhibitor | 0.149 0.021 DBMET00584 | ||
| 0.398 | 0.036 | 0.614 | Vasodilator, coronary | 0.614 0.007 DBMET00584 | DBMET00584 | |
| 0.386 | 0.024 | 0.386 | Insulysin inhibitor | |||
| 0.363 | 0.011 | 0.363 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.271 0.034 DBMET00584 | ||
| 0.361 | 0.008 | 0.361 | Gastrin inhibitor | 0.274 0.053 DBMET00584 | ||
| 0.355 | 0.004 | 0.355 | Prostaglandin E2 antagonist | |||
| 0.356 | 0.013 | 0.356 | Lipocortins synthesis antagonist | 0.184 0.067 DBMET00584 | ||
| 0.345 | 0.007 | 0.346 | Hexokinase inhibitor | 0.346 0.006 DBMET00584 | DBMET00584 | |
| 0.332 | 0.004 | 0.332 | GABA C receptor antagonist | |||
| 0.349 | 0.024 | 0.349 | RNA-directed DNA polymerase inhibitor | 0.257 0.046 DBMET00584 | ||
| 0.367 | 0.046 | 0.367 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | |||
| 0.322 | 0.005 | 0.322 | Carbonic anhydrase III inhibitor | 0.153 0.027 DBMET00584 | ||
| 0.343 | 0.027 | 0.429 | Cyclic AMP phosphodiesterase inhibitor | 0.429 0.013 DBMET00584 | DBMET00584 | |
| 0.32 | 0.005 | 0.32 | Mannose-6-phosphate isomerase inhibitor | 0.313 0.005 DBMET00584 | ||
| 0.319 | 0.004 | 0.319 | Argininosuccinate synthase inhibitor | 0.143 0.012 DBMET00584 | ||
| 0.322 | 0.009 | 0.322 | Protein-tyrosine phosphatase 1B inhibitor | 0.3 0.011 DBMET00584 | ||
| 0.379 | 0.068 | 0.768 | Transcription factor NF kappa B inhibitor | 0.768 0.015 DBMET00584 | DBMET00584 | |
| 0.325 | 0.019 | 0.331 | DNA methyltransferase I inhibitor | 0.331 0.017 DBMET00584 | DBMET00584 | |
| 0.312 | 0.009 | 0.312 | 3C-like protease (Human coronavirus) inhibitor | |||
| 0.304 | 0.003 | 0.304 | GABA C receptor rho-1 antagonist | |||
| 0.316 | 0.016 | 0.639 | Amylase inhibitor | 0.639 0.004 DBMET00584 | DBMET00584 | |
| 0.336 | 0.038 | 0.336 | Transcription factor STAT3 inhibitor | 0.208 0.123 DBMET00584 | ||
| 0.335 | 0.04 | 0.335 | Transcription factor STAT inhibitor | 0.177 0.173 DBMET00584 | ||
| 0.333 | 0.039 | 0.333 | Pyruvate kinase inhibitor | |||
| 0.314 | 0.024 | 0.387 | DNA methylase inhibitor | 0.387 0.012 DBMET00584 | DBMET00584 | |
| 0.29 | 0.006 | 0.356 | Phosphofructokinase-1 inhibitor | 0.356 0.004 DBMET00584 | DBMET00584 | |
| 0.342 | 0.06 | 0.658 | Apoptosis antagonist | 0.658 0.005 DBMET00584 | DBMET00584 | |
| 0.324 | 0.042 | 0.418 | Hypolipemic | 0.418 0.022 DBMET00584 | DBMET00584 | |
| 0.285 | 0.005 | 0.285 | Prostaglandin antagonist | |||
| 0.285 | 0.005 | 0.285 | Potassium channel (Ca-activated) activator | 0.115 0.044 DBMET00584 | ||
| 0.292 | 0.015 | 0.292 | Phospholipase A2 inhibitor | 0.201 0.042 DBMET00584 | ||
| 0.303 | 0.027 | 0.557 | Non-steroidal antiinflammatory agent | 0.557 0.005 DBMET00584 | DBMET00584 | |
| 0.282 | 0.007 | 0.282 | GABA C receptor rho-2 antagonist | |||
| 0.295 | 0.021 | 0.373 | Interferon gamma antagonist | 0.373 0.012 DBMET00584 | DBMET00584 | |
| 0.28 | 0.007 | 0.28 | Carbonic anhydrase VI inhibitor | 0.131 0.025 DBMET00584 | ||
| 0.406 | 0.136 | 0.882 | Antiinflammatory | 0.882 0.006 DBMET00584 | DBMET00584 | |
| 0.277 | 0.007 | 0.277 | Catalase inhibitor | |||
| 0.275 | 0.005 | 0.275 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | |||
| 0.288 | 0.02 | 0.45 | NOS3 expression enhancer | 0.45 0.006 DBMET00584 | DBMET00584 | |
| 0.276 | 0.01 | 0.276 | Aminopeptidase B inhibitor | |||
| 0.322 | 0.06 | 0.558 | Interleukin 2 agonist | 0.558 0.004 DBMET00584 | DBMET00584 | |
| 0.286 | 0.025 | 0.286 | Diuretic | 0.231 0.035 DBMET00584 | ||
| 0.321 | 0.062 | 0.538 | Spasmolytic | 0.538 0.019 DBMET00584 | DBMET00584 | |
| 0.262 | 0.003 | 0.262 | Nicotinic acid receptor 2 agonist | |||
| 0.27 | 0.013 | 0.418 | Cell wall synthesis inhibitor | 0.418 0.005 DBMET00584 | DBMET00584 | |
| 0.273 | 0.016 | 0.273 | M17 leucyl aminopeptidase inhibitor | |||
| 0.278 | 0.022 | 0.278 | Insulin sensitizer | 0.207 0.066 DBMET00584 | ||
| 0.261 | 0.004 | 0.261 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.269 | 0.015 | 0.269 | Cholesterol synthesis inhibitor | 0.173 0.035 DBMET00584 | ||
| 0.255 | 0.002 | 0.255 | Retinoic acid beta receptor agonist | |||
| 0.303 | 0.052 | 0.467 | Platelet antagonist | 0.467 0.017 DBMET00584 | DBMET00584 | |
| 0.271 | 0.021 | 0.272 | Nitric-oxide synthase stimulant | 0.272 0.02 DBMET00584 | DBMET00584 | |
| 0.26 | 0.011 | 0.341 | Xanthine oxidase inhibitor | 0.341 0.005 DBMET00584 | DBMET00584 | |
| 0.266 | 0.017 | 0.489 | Insulin secretagoues | 0.489 0.005 DBMET00584 | DBMET00584 | |
| 0.252 | 0.003 | 0.252 | Glutamate (mGluR3) antagonist | |||
| 0.251 | 0.003 | 0.251 | Acyl-CoA dehydrogenase inhibitor | 0.117 0.013 DBMET00584 | ||
| 0.249 | 0.004 | 0.249 | DOPA decarboxylase inhibitor | |||
| 0.269 | 0.026 | 0.269 | Amyloid beta precursor protein antagonist | |||
| 0.247 | 0.005 | 0.247 | Prostaglandin EP2 antagonist | 0.062 0.039 DBMET00584 | ||
| 0.243 | 0.005 | 0.243 | Potassium channel large-conductance Ca-activated activator | 0.07 0.044 DBMET00584 | ||
| 0.249 | 0.011 | 0.249 | Catenin beta inhibitor | |||
| 0.24 | 0.002 | 0.24 | Retinoic acid alpha receptor agonist | 0.041 0.024 DBMET00584 | ||
| 0.25 | 0.013 | 0.551 | Expectorant | 0.551 0.003 DBMET00584 | DBMET00584 | |
| 0.24 | 0.003 | 0.24 | Fumarate hydratase inhibitor | 0.061 0.01 DBMET00584 | ||
| 0.238 | 0.002 | 0.238 | Glutamate (mGluR6) antagonist | 0.078 0.026 DBMET00584 | ||
| 0.24 | 0.009 | 0.24 | Carbonic anhydrase XIII inhibitor | 0.132 0.026 DBMET00584 | ||
| 0.24 | 0.01 | 0.492 | Cyclooxygenase 3 inhibitor | 0.492 0.003 DBMET00584 | DBMET00584 | |
| 0.237 | 0.008 | 0.262 | Mucolytic | 0.262 0.005 DBMET00584 | DBMET00584 | |
| 0.327 | 0.099 | 0.57 | Immunosuppressant | 0.57 0.017 DBMET00584 | DBMET00584 | |
| 0.231 | 0.002 | 0.231 | Retinoid X beta receptor agonist | |||
| 0.252 | 0.024 | 0.513 | Monophenol monooxygenase inhibitor | 0.513 0.007 DBMET00584 | DBMET00584 | |
| 0.229 | 0.002 | 0.229 | Ca2+-transporting ATPase inhibitor | 0.206 0.003 DBMET00584 | ||
| 0.231 | 0.005 | 0.231 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.23 | 0.005 | 0.23 | Aminopeptidase I inhibitor | 0.071 0.052 DBMET00584 | ||
| 0.259 | 0.034 | 0.259 | Neurotrophic factor enhancer | 0.251 0.038 DBMET00584 | ||
| 0.246 | 0.022 | 0.246 | NADPH oxidase inhibitor | 0.132 0.069 DBMET00584 | ||
| 0.252 | 0.029 | 0.252 | Cytidine deaminase inhibitor | |||
| 0.291 | 0.07 | 0.356 | Hypoxia-inducible factor 1 alpha inhibitor | 0.356 0.043 DBMET00584 | DBMET00584 | |
| 0.232 | 0.011 | 0.232 | Arachidonic acid antagonist | 0.184 0.049 DBMET00584 | ||
| 0.227 | 0.007 | 0.227 | TRPA1 agonist | 0.134 0.044 DBMET00584 | ||
| 0.254 | 0.036 | 0.254 | I kappa B kinase epsilon inhibitor | |||
| 0.22 | 0.003 | 0.22 | NMDA 2D receptor antagonist | |||
| 0.221 | 0.005 | 0.221 | Heat shock protein 70 antagonist | 0.173 0.015 DBMET00584 | ||
| 0.274 | 0.059 | 0.722 | Free radical scavenger | 0.722 0.005 DBMET00584 | DBMET00584 | |
| 0.296 | 0.082 | 0.296 | 12-Lipoxygenase inhibitor | |||
| 0.218 | 0.004 | 0.218 | NMDA receptor agonist | |||
| 0.219 | 0.006 | 0.219 | Ornithine carbamoyltransferase inhibitor | 0.074 0.024 DBMET00584 | ||
| 0.217 | 0.004 | 0.217 | Neuraminidase (influenza) inhibitor | 0.203 0.005 DBMET00584 | ||
| 0.22 | 0.008 | 0.22 | ABCA1 expression enhancer | |||
| 0.24 | 0.029 | 0.352 | Protein kinase stimulant | 0.352 0.012 DBMET00584 | DBMET00584 | |
| 0.214 | 0.004 | 0.214 | Ornithine decarboxylase inhibitor | 0.114 0.03 DBMET00584 | ||
| 0.226 | 0.017 | 0.226 | Cathepsin H inhibitor | |||
| 0.324 | 0.115 | 0.324 | 15-Lipoxygenase inhibitor | |||
| 0.21 | 0.003 | 0.21 | Purinergic P2X1 antagonist | 0.136 0.009 DBMET00584 | ||
| 0.211 | 0.004 | 0.211 | CD45 antagonist | |||
| 0.208 | 0.003 | 0.208 | Nicotinic acid receptor agonist | |||
| 0.22 | 0.015 | 0.22 | Protein kinase (CK2) inhibitor | |||
| 0.207 | 0.003 | 0.207 | Retinoic acid receptor agonist | 0.022 0.017 DBMET00584 | ||
| 0.208 | 0.004 | 0.208 | Glycine receptor agonist | 0.137 0.009 DBMET00584 | ||
| 0.236 | 0.032 | 0.236 | Histone acetyltransferase inhibitor | |||
| 0.309 | 0.108 | 0.309 | Calpain 2 inhibitor | |||
| 0.205 | 0.004 | 0.205 | Plasminogen activator inhibitor antagonist | |||
| 0.222 | 0.023 | 0.319 | ATPase inhibitor | 0.319 0.005 DBMET00584 | DBMET00584 | |
| 0.216 | 0.018 | 0.216 | Farnesoid X receptor antagonist | |||
| 0.209 | 0.011 | 0.264 | Photosensitizer | 0.264 0.005 DBMET00584 | DBMET00584 | |
| 0.217 | 0.021 | 0.217 | Protein kinase (CK2) alpha inhibitor | |||
| 0.201 | 0.008 | 0.201 | Macrophage migration inhibitory factor inhibitor | |||
| 0.276 | 0.084 | 0.276 | Lipoxygenase inhibitor | |||
| 0.195 | 0.003 | 0.195 | D-Ala-D-Ala ligase inhibitor | |||
| 0.2 | 0.009 | 0.2 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.264 | 0.073 | 0.264 | Aryl hydrocarbon receptor agonist | |||
| 0.198 | 0.008 | 0.198 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.213 | 0.024 | 0.296 | DNA polymerase I inhibitor | 0.296 0.012 DBMET00584 | DBMET00584 | |
| 0.203 | 0.013 | 0.203 | Protein kinase C gamma inhibitor | 0.165 0.024 DBMET00584 | ||
| 0.189 | 0.001 | 0.189 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.041 0.029 DBMET00584 | ||
| 0.264 | 0.077 | 0.779 | Antioxidant | 0.779 0.005 DBMET00584 | DBMET00584 | |
| 0.274 | 0.087 | 0.581 | Immunostimulant | 0.581 0.019 DBMET00584 | DBMET00584 | |
| 0.207 | 0.021 | 0.207 | Toll-Like receptor 2 antagonist | 0.12 0.077 DBMET00584 | ||
| 0.19 | 0.004 | 0.19 | Neuraminidase inhibitor | 0.153 0.005 DBMET00584 | ||
| 0.213 | 0.028 | 0.447 | Hemostatic | 0.447 0.005 DBMET00584 | DBMET00584 | |
| 0.188 | 0.004 | 0.188 | Prostaglandin EP1 antagonist | |||
| 0.195 | 0.012 | 0.555 | AMP-activated protein kinase stimulant | 0.555 0.003 DBMET00584 | DBMET00584 | |
| 0.198 | 0.015 | 0.453 | Mediator release inhibitor | 0.453 0.004 DBMET00584 | DBMET00584 | |
| 0.188 | 0.005 | 0.188 | Xanthine dehydrogenase inhibitor | 0.089 0.02 DBMET00584 | ||
| 0.191 | 0.01 | 0.191 | HIV-1 integrase (3'-Processing) inhibitor | 0.066 0.041 DBMET00584 | ||
| 0.222 | 0.042 | 0.409 | Thrombolytic | 0.409 0.01 DBMET00584 | DBMET00584 | |
| 0.181 | 0.003 | 0.181 | Glutamate (mGluR4) antagonist | |||
| 0.248 | 0.071 | 0.871 | Angiogenesis stimulant | 0.871 0.003 DBMET00584 | DBMET00584 | |
| 0.2 | 0.024 | 0.2 | Chelator | |||
| 0.179 | 0.003 | 0.179 | Dihydroorotase inhibitor | |||
| 0.207 | 0.031 | 0.207 | Neurotensin receptor agonist | |||
| 0.215 | 0.041 | 0.215 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.21 | 0.037 | 0.381 | Melanin inhibitor | 0.381 0.013 DBMET00584 | DBMET00584 | |
| 0.199 | 0.026 | 0.199 | Adenylate cyclase inhibitor | 0.152 0.044 DBMET00584 | ||
| 0.185 | 0.011 | 0.185 | NAD(P)H dehydrogenase (quinone) inhibitor | |||
| 0.176 | 0.003 | 0.176 | Glutamate (mGluR group III) antagonist | |||
| 0.235 | 0.062 | 0.438 | Peptidyltransferase inhibitor | 0.438 0.005 DBMET00584 | DBMET00584 | |
| 0.176 | 0.005 | 0.176 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.117 0.013 DBMET00584 | ||
| 0.202 | 0.032 | 0.202 | Anesthetic local | |||
| 0.194 | 0.024 | 0.194 | Interleukin 4 antagonist | 0.183 0.028 DBMET00584 | ||
| 0.18 | 0.011 | 0.18 | HIV-1 integrase (Strand Transfer) inhibitor | 0.057 0.044 DBMET00584 | ||
| 0.222 | 0.053 | 0.691 | Hepatoprotectant | 0.691 0.004 DBMET00584 | DBMET00584 | |
| 0.189 | 0.022 | 0.261 | Microtubule formation inhibitor | 0.261 0.006 DBMET00584 | DBMET00584 | |
| 0.173 | 0.007 | 0.173 | Carbonic anhydrase VB inhibitor | |||
| 0.186 | 0.022 | 0.186 | Adenylate cyclase stimulant | 0.176 0.029 DBMET00584 | ||
| 0.175 | 0.013 | 0.175 | Glutamate receptor agonist | |||
| 0.171 | 0.01 | 0.171 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | |||
| 0.227 | 0.067 | 0.261 | Psychostimulant | 0.261 0.055 DBMET00584 | DBMET00584 | |
| 0.233 | 0.073 | 0.233 | Neuropeptide Y2 antagonist | |||
| 0.163 | 0.003 | 0.163 | Adenine nucleotide translocase inhibitor | 0.111 0.004 DBMET00584 | ||
| 0.237 | 0.077 | 0.454 | Antiamyloidogenic | 0.454 0.021 DBMET00584 | DBMET00584 | |
| 0.169 | 0.009 | 0.169 | Carbamoyl phosphate synthetase inhibitor | 0.098 0.021 DBMET00584 | ||
| 0.163 | 0.004 | 0.163 | GABA B receptor agonist | |||
| 0.162 | 0.004 | 0.162 | TRPM8 blocker | |||
| 0.165 | 0.007 | 0.227 | Glutamate release inhibitor | 0.227 0.004 DBMET00584 | DBMET00584 | |
| 0.168 | 0.011 | 0.168 | Carbonic anhydrase V inhibitor | |||
| 0.171 | 0.015 | 0.171 | Prolactin inhibitor | |||
| 0.159 | 0.004 | 0.159 | NMDA receptor glycine site agonist | |||
| 0.191 | 0.036 | 0.191 | M18 aspartyl aminopeptidase inhibitor | |||
| 0.161 | 0.007 | 0.161 | Autotaxin inhibitor | |||
| 0.195 | 0.041 | 0.195 | Thiol protease inhibitor | |||
| 0.172 | 0.019 | 0.172 | NMDA receptor antagonist | |||
| 0.185 | 0.032 | 0.185 | CF transmembrane conductance regulator agonist | 0.184 0.033 DBMET00584 | ||
| 0.155 | 0.003 | 0.155 | Retinoid X alpha receptor agonist | |||
| 0.156 | 0.004 | 0.156 | Kainate receptor antagonist | |||
| 0.155 | 0.005 | 0.155 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.162 | 0.013 | 0.162 | Anabolic | 0.125 0.035 DBMET00584 | ||
| 0.159 | 0.011 | 0.159 | Histamine N-methyltransferase inhibitor | |||
| 0.174 | 0.027 | 0.174 | Falcipain 3 inhibitor | |||
| 0.149 | 0.002 | 0.149 | Retinoid X gamma receptor agonist | |||
| 0.178 | 0.032 | 0.41 | Cell adhesion inhibitor | 0.41 0.005 DBMET00584 | DBMET00584 | |
| 0.249 | 0.103 | 0.249 | Streptokinase A inhibitor | |||
| 0.185 | 0.039 | 0.185 | Alkaline phosphatase inhibitor | 0.171 0.047 DBMET00584 | ||
| 0.159 | 0.013 | 0.163 | CC chemokine 6 receptor antagonist | 0.163 0.011 DBMET00584 | DBMET00584 | |
| 0.151 | 0.007 | 0.151 | Bile acid receptor antagonist | 0.1 0.049 DBMET00584 | ||
| 0.163 | 0.02 | 0.163 | Caspase 3 inhibitor | |||
| 0.302 | 0.16 | 0.302 | DNA directed DNA polymerase inhibitor | |||
| 0.151 | 0.011 | 0.151 | Carbonic anhydrase VA inhibitor | |||
| 0.303 | 0.164 | 0.303 | DNA polymerase beta inhibitor | |||
| 0.146 | 0.006 | 0.146 | NMDA receptor subunit 3B antagonist | |||
| 0.227 | 0.088 | 0.227 | Calpain inhibitor | |||
| 0.146 | 0.008 | 0.196 | Glycine receptor antagonist | 0.196 0.004 DBMET00584 | DBMET00584 | |
| 0.138 | 0.002 | 0.138 | Retinoic acid beta receptor antagonist | |||
| 0.138 | 0.003 | 0.138 | Dihydroorotate oxidase inhibitor | |||
| 0.148 | 0.013 | 0.148 | Peroxisome proliferator-activated receptor gamma agonist | |||
| 0.138 | 0.005 | 0.138 | Prostaglandin F2 alpha antagonist | |||
| 0.173 | 0.04 | 0.289 | Topoisomerase II inhibitor | 0.289 0.019 DBMET00584 | DBMET00584 | |
| 0.16 | 0.028 | 0.16 | Interleukin 8 antagonist | |||
| 0.137 | 0.005 | 0.137 | Dihydroorotate dehydrogenase inhibitor | |||
| 0.145 | 0.013 | 0.145 | Glutathione S-transferase inhibitor | |||
| 0.226 | 0.095 | 0.343 | DNA damaging | 0.343 0.043 DBMET00584 | DBMET00584 | |
| 0.151 | 0.021 | 0.151 | Cathepsin G inhibitor | |||
| 0.152 | 0.022 | 0.152 | Urease inhibitor | |||
| 0.132 | 0.004 | 0.132 | Glutamate (mGluR7) antagonist | |||
| 0.131 | 0.003 | 0.131 | Retinoid X receptor agonist | |||
| 0.218 | 0.091 | 0.571 | Vasodilator | 0.571 0.007 DBMET00584 | DBMET00584 | |
| 0.186 | 0.059 | 0.186 | Antipruritic | |||
| 0.15 | 0.025 | 0.615 | Beta glucuronidase inhibitor | 0.615 0.003 DBMET00584 | DBMET00584 | |
| 0.17 | 0.044 | 0.17 | Neurotrophic factor | |||
| 0.13 | 0.006 | 0.13 | Glutamate (mGluR group III) agonist | |||
| 0.165 | 0.041 | 0.165 | Glutamate receptor antagonist | |||
| 0.125 | 0.002 | 0.125 | Retinoic acid receptor gamma antagonist | 0.011 0.009 DBMET00584 | ||
| 0.128 | 0.005 | 0.128 | Leukotriene A4 hydrolase inhibitor | |||
| 0.123 | 0.002 | 0.123 | Retinoic acid alpha receptor antagonist | |||
| 0.127 | 0.007 | 0.127 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | |||
| 0.123 | 0.003 | 0.123 | GABA uptake inhibitor | |||
| 0.129 | 0.009 | 0.241 | Phosphorylase inhibitor | 0.241 0.004 DBMET00584 | DBMET00584 | |
| 0.137 | 0.018 | 0.137 | Glutamate (mGluR7) agonist | |||
| 0.162 | 0.043 | 0.162 | MAP kinase kinase 4 inhibitor | |||
| 0.128 | 0.009 | 0.128 | CDC25B inhibitor | |||
| 0.12 | 0.002 | 0.12 | Glutamate (mGluR8) agonist | 0.035 0.034 DBMET00584 | ||
| 0.136 | 0.018 | 0.136 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.128 | 0.01 | 0.182 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.182 0.007 DBMET00584 | DBMET00584 | |
| 0.149 | 0.032 | 0.233 | DNA repair enzyme inhibitor | 0.233 0.006 DBMET00584 | DBMET00584 | |
| 0.133 | 0.016 | 0.133 | Interleukin 5 antagonist | |||
| 0.121 | 0.004 | 0.121 | Neuraminidase (Influenza A) inhibitor | 0.091 0.004 DBMET00584 | ||
| 0.124 | 0.009 | 0.124 | Estrogen-related receptor beta agonist | |||
| 0.129 | 0.014 | 0.129 | Leukotriene antagonist | 0.069 0.041 DBMET00584 | ||
| 0.118 | 0.003 | 0.118 | Kynurenine 3 monooxygenase inhibitor | 0.026 0.019 DBMET00584 | ||
| 0.12 | 0.006 | 0.12 | Nicotinic acid receptor 1 agonist | |||
| 0.117 | 0.002 | 0.117 | Retinoic acid receptor antagonist | 0.017 0.015 DBMET00584 | ||
| 0.244 | 0.13 | 0.244 | Prostaglandin dehydrogenase inhibitor | |||
| 0.283 | 0.169 | 0.736 | Alpha-glucosidase inhibitor | 0.736 0.028 DBMET00584 | DBMET00584 | |
| 0.124 | 0.011 | 0.182 | Protein kinase C eta inhibitor | 0.182 0.005 DBMET00584 | DBMET00584 | |
| 0.12 | 0.007 | 0.12 | NMDA receptor subunit 3A antagonist | |||
| 0.119 | 0.007 | 0.119 | Phospholipase D inhibitor | |||
| 0.121 | 0.01 | 0.121 | Maillard reaction inhibitor | |||
| 0.132 | 0.021 | 0.132 | NMDA 2 receptor antagonist | |||
| 0.114 | 0.003 | 0.114 | Glutamate (mGluR1) agonist | |||
| 0.118 | 0.008 | 0.118 | 5-Alpha-reductase inhibitor | |||
| 0.175 | 0.066 | 0.175 | Heat shock protein 90 alpha antagonist | |||
| 0.12 | 0.01 | 0.12 | NMDA 2C receptor antagonist | |||
| 0.114 | 0.005 | 0.114 | Urate transporter 1 inhibitor | |||
| 0.116 | 0.007 | 0.116 | Topoisomerase II beta inhibitor | 0.052 0.029 DBMET00584 | ||
| 0.147 | 0.039 | 0.147 | 5-Lipoxygenase inhibitor | |||
| 0.122 | 0.014 | 0.122 | HIV-1 integrase inhibitor | |||
| 0.148 | 0.041 | 0.15 | Vanilloid 1 agonist | 0.15 0.038 DBMET00584 | DBMET00584 | |
| 0.115 | 0.008 | 0.149 | Carbonic anhydrase XIV inhibitor | 0.149 0.005 DBMET00584 | DBMET00584 | |
| 0.109 | 0.004 | 0.109 | Glutamate (mGluR1a) agonist | |||
| 0.11 | 0.005 | 0.276 | Mannosidase inhibitor | 0.276 0.002 DBMET00584 | DBMET00584 | |
| 0.109 | 0.004 | 0.109 | Dihydropteroate synthase inhibitor | |||
| 0.111 | 0.006 | 0.111 | MAP kinase kinase 7 inhibitor | |||
| 0.109 | 0.005 | 0.109 | MDM2 inhibitor | |||
| 0.12 | 0.017 | 0.12 | Leukotriene synthesis inhibitor | |||
| 0.133 | 0.03 | 0.145 | Acetylcholine release stimulant | 0.145 0.019 DBMET00584 | DBMET00584 | |
| 0.105 | 0.002 | 0.105 | Retinoic acid gamma receptor agonist | |||
| 0.216 | 0.113 | 0.216 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.11 | 0.007 | 0.11 | Potassium channel intermediate-conductance Ca-activated blocker | |||
| 0.107 | 0.005 | 0.107 | RNA-directed RNA polymerase inhibitor | |||
| 0.107 | 0.004 | 0.107 | Lysophosphatidic acid 3 receptor antagonist | |||
| 0.107 | 0.005 | 0.107 | AMPA 4 receptor antagonist | |||
| 0.107 | 0.005 | 0.107 | Carnitine palmitoyltransferase 1B inhibitor | |||
| 0.118 | 0.017 | 0.118 | Sphingosine 1-phosphate receptor 4 agonist | |||
| 0.105 | 0.004 | 0.158 | Glucose-6-phosphate isomerase inhibitor | 0.158 0.002 DBMET00584 | DBMET00584 | |
| 0.105 | 0.005 | 0.105 | 5-Alpha-reductase 2 inhibitor | |||
| 0.13 | 0.03 | 0.13 | Calcium antagonist | |||
| 0.114 | 0.014 | 0.114 | DNA gyrase inhibitor | |||
| 0.111 | 0.011 | 0.111 | Peroxisome proliferator-activated receptor gamma antagonist | |||
| 0.13 | 0.03 | 0.13 | Factor V inhibitor | |||
| 0.147 | 0.048 | 0.147 | Antibacterial (Helicobacter pylori) | |||
| 0.102 | 0.004 | 0.102 | Prostaglandin EP4 agonist | |||
| 0.108 | 0.01 | 0.111 | Protein kinase C beta inhibitor | 0.111 0.009 DBMET00584 | DBMET00584 | |
| 0.101 | 0.005 | 0.101 | Factor III inhibitor | 0.06 0.018 DBMET00584 | ||
| 0.107 | 0.01 | 0.107 | AMPA receptor antagonist | |||
| 0.099 | 0.004 | 0.099 | Pregnane X receptor antagonist | |||
| 0.145 | 0.049 | 0.317 | Alkylator | 0.317 0.012 DBMET00584 | DBMET00584 | |
| 0.126 | 0.03 | 0.126 | Interleukin 1 beta converting enzyme inhibitor | |||
| 0.105 | 0.01 | 0.105 | S-adenosyl-L-methionine decarboxylase inhibitor | |||
| 0.105 | 0.01 | 0.105 | Thromboxane antagonist | |||
| 0.1 | 0.005 | 0.1 | Kainate receptor 2 antagonist | |||
| 0.134 | 0.039 | 0.134 | Transcription factor STAT6 inhibitor | |||
| 0.101 | 0.006 | 0.101 | Thromboxane synthase inhibitor | |||
| 0.098 | 0.004 | 0.098 | Prostaglandin EP4 antagonist | |||
| 0.096 | 0.002 | 0.096 | Nicotinic acid receptor 2 antagonist | |||
| 0.28 | 0.187 | 0.756 | Apoptosis agonist | 0.756 0.022 DBMET00584 | DBMET00584 | |
| 0.098 | 0.004 | 0.098 | Farnesoid X receptor agonist | |||
| 0.097 | 0.004 | 0.097 | Kainate receptor 1 antagonist | |||
| 0.102 | 0.01 | 0.102 | Leukotriene B4 antagonist | 0.087 0.013 DBMET00584 | ||
| 0.117 | 0.025 | 0.279 | Cell adhesion molecule inhibitor | 0.279 0.005 DBMET00584 | DBMET00584 | |
| 0.113 | 0.021 | 0.113 | Prostaglandin-E synthase inhibitor | |||
| 0.127 | 0.036 | 0.127 | Sphingomyelinase inhibitor | 0.126 0.037 DBMET00584 | ||
| 0.097 | 0.006 | 0.097 | Guanylate cyclase stimulant | |||
| 0.117 | 0.027 | 0.285 | Transcription factor NF kappa B stimulant | 0.285 0.004 DBMET00584 | DBMET00584 | |
| 0.094 | 0.004 | 0.094 | Methionyl aminopeptidase 2 inhibitor | |||
| 0.183 | 0.093 | 0.183 | MAP kinase kinase 2 inhibitor | |||
| 0.113 | 0.024 | 0.494 | Selectin antagonist | 0.494 0.003 DBMET00584 | DBMET00584 | |
| 0.117 | 0.027 | 0.117 | Adrenaline agonist | |||
| 0.093 | 0.003 | 0.093 | Nerve growth factor antagonist | |||
| 0.092 | 0.003 | 0.092 | Kainate receptor agonist | 0.04 0.033 DBMET00584 | ||
| 0.092 | 0.002 | 0.092 | Glutamate (mGluR3) agonist | 0.033 0.02 DBMET00584 | ||
| 0.117 | 0.028 | 0.176 | Phosphodiesterase 6D inhibitor | 0.176 0.005 DBMET00584 | DBMET00584 | |
| 0.097 | 0.009 | 0.097 | Sphingosine 1-phosphate receptor 3 antagonist | |||
| 0.121 | 0.034 | 0.121 | MAP kinase kinase 1 inhibitor | |||
| 0.095 | 0.007 | 0.271 | Alpha-mannosidase inhibitor | 0.271 0.002 DBMET00584 | DBMET00584 | |
| 0.1 | 0.013 | 0.1 | NMDA 2A receptor antagonist | |||
| 0.091 | 0.005 | 0.091 | HCV NS5B polymerase inhibitor | |||
| 0.09 | 0.005 | 0.09 | Ryanodine receptor antagonist | |||
| 0.11 | 0.025 | 0.11 | 3C-Like protease (SARS coronavirus) inhibitor | |||
| 0.094 | 0.009 | 0.094 | Thromboxane A2 antagonist | |||
| 0.089 | 0.005 | 0.251 | Heparanase inhibitor | 0.251 0.002 DBMET00584 | DBMET00584 | |
| 0.092 | 0.008 | 0.092 | Glutamate (mGluR group II) agonist | |||
| 0.097 | 0.013 | 0.097 | Peroxisome proliferator-activated receptor alpha agonist | |||
| 0.089 | 0.006 | 0.089 | Prostaglandin agonist | |||
| 0.088 | 0.005 | 0.088 | Leukotriene C antagonist | |||
| 0.086 | 0.005 | 0.086 | 5-Alpha-reductase 1 inhibitor | |||
| 0.102 | 0.02 | 0.102 | Sphingosine 1-phosphate receptor antagonist | |||
| 0.085 | 0.004 | 0.085 | Protein kinase (CK2) beta inhibitor | |||
| 0.105 | 0.025 | 0.105 | CDC25A inhibitor | |||
| 0.088 | 0.008 | 0.088 | DNA helicase inhibitor | |||
| 0.119 | 0.04 | 0.119 | Folate antagonist | |||
| 0.104 | 0.025 | 0.185 | Interferon agonist | 0.185 0.007 DBMET00584 | DBMET00584 | |
| 0.085 | 0.006 | 0.085 | AICAR transformylase inhibitor | |||
| 0.089 | 0.01 | 0.089 | Diacylglycerol O-acyltransferase inhibitor | |||
| 0.082 | 0.003 | 0.082 | Retinoid X receptor antagonist | |||
| 0.082 | 0.004 | 0.082 | Kainate receptor 5 antagonist | |||
| 0.085 | 0.008 | 0.085 | Adenosine deaminase inhibitor | 0.074 0.011 DBMET00584 | ||
| 0.091 | 0.014 | 0.091 | Exportin-1 inhibitor | |||
| 0.105 | 0.029 | 0.105 | Myeloperoxidase inhibitor | |||
| 0.078 | 0.003 | 0.078 | Guanylate cyclase inhibitor | 0.071 0.004 DBMET00584 | ||
| 0.146 | 0.071 | 0.146 | Neuropeptide Y1 antagonist | |||
| 0.078 | 0.004 | 0.078 | Uridine phosphorylase inhibitor | 0.07 0.004 DBMET00584 | ||
| 0.129 | 0.055 | 0.129 | Interleukin 1b antagonist | 0.102 0.078 DBMET00584 | ||
| 0.082 | 0.008 | 0.082 | Factor XIa inhibitor | |||
| 0.105 | 0.031 | 0.105 | Hematopoietic | |||
| 0.087 | 0.014 | 0.123 | Factor IXa inhibitor | 0.123 0.005 DBMET00584 | DBMET00584 | |
| 0.148 | 0.076 | 0.148 | Acetylcholine M1 receptor antagonist | |||
| 0.081 | 0.008 | 0.081 | Glutamate (mGluR2) agonist | |||
| 0.081 | 0.009 | 0.105 | Squalene epoxidase inhibitor | 0.105 0.005 DBMET00584 | DBMET00584 | |
| 0.079 | 0.007 | 0.079 | AMPA 1 receptor antagonist | |||
| 0.146 | 0.074 | 0.146 | MAP kinase 3 inhibitor | |||
| 0.078 | 0.006 | 0.079 | Arginase inhibitor | 0.079 0.006 DBMET00584 | DBMET00584 | |
| 0.075 | 0.004 | 0.075 | Glutamate (mGluR8) antagonist | |||
| 0.117 | 0.046 | 0.117 | Gastric antisecretory | |||
| 0.076 | 0.005 | 0.076 | Geranyltranstransferase inhibitor | |||
| 0.159 | 0.089 | 0.159 | Tumour necrosis factor antagonist | |||
| 0.096 | 0.026 | 0.096 | Calcium channel L-type blocker | |||
| 0.076 | 0.006 | 0.076 | Dopamine beta hydroxylase inhibitor | |||
| 0.136 | 0.066 | 0.136 | Cyclooxygenase 1 inhibitor | 0.123 0.077 DBMET00584 | ||
| 0.082 | 0.012 | 0.082 | Purinergic P2Y antagonist | |||
| 0.077 | 0.008 | 0.077 | Somatostatin 5 antagonist | |||
| 0.071 | 0.003 | 0.071 | Retinoid X alpha receptor antagonist | |||
| 0.074 | 0.006 | 0.074 | Membrane dipeptidase inhibitor | |||
| 0.161 | 0.094 | 0.589 | Platelet adhesion inhibitor | 0.589 0.004 DBMET00584 | DBMET00584 | |
| 0.14 | 0.074 | 0.14 | Pregnane X receptor agonist | |||
| 0.091 | 0.025 | 0.091 | Vanilloid 4 agonist | |||
| 0.085 | 0.02 | 0.136 | Interferon inducer | 0.136 0.005 DBMET00584 | DBMET00584 | |
| 0.098 | 0.033 | 0.123 | Na+ K+ transporting ATPase inhibitor | 0.123 0.014 DBMET00584 | DBMET00584 | |
| 0.078 | 0.013 | 0.078 | Sphingosine 1-phosphate receptor 5 agonist | |||
| 0.072 | 0.008 | 0.072 | Dopamine D5 agonist | |||
| 0.068 | 0.004 | 0.068 | Calcium-sensing receptor agonist | |||
| 0.073 | 0.009 | 0.073 | Immunoglobulin Fc receptor antagonist | |||
| 0.136 | 0.072 | 0.136 | Nav1.6 sodium channel blocker | |||
| 0.067 | 0.004 | 0.067 | Angiotensin II receptor antagonist | |||
| 0.071 | 0.008 | 0.071 | GABA B receptor antagonist | |||
| 0.066 | 0.004 | 0.066 | Angiotensin AT1 receptor antagonist | |||
| 0.067 | 0.005 | 0.067 | Free fatty acid receptor 1 antagonist | |||
| 0.064 | 0.002 | 0.064 | Retinoid X beta receptor antagonist | |||
| 0.071 | 0.009 | 0.071 | Phosphoglycerate kinase inhibitor | 0.033 0.027 DBMET00584 | ||
| 0.088 | 0.027 | 0.088 | Glutamate (mGluR) agonist | |||
| 0.066 | 0.005 | 0.066 | Leukotriene B4 receptor 1 antagonist | |||
| 0.075 | 0.014 | 0.075 | Carbonic anhydrase VII inhibitor | |||
| 0.067 | 0.007 | 0.067 | Glutamate (mGluR4) agonist | |||
| 0.064 | 0.004 | 0.064 | Prostaglandin EP2 agonist | |||
| 0.137 | 0.078 | 0.455 | Lipid peroxidase inhibitor | 0.455 0.007 DBMET00584 | DBMET00584 | |
| 0.082 | 0.023 | 0.082 | Glutamate (mGluR1) antagonist | |||
| 0.063 | 0.005 | 0.063 | Carnitine palmitoyltransferase inhibitor | |||
| 0.083 | 0.025 | 0.083 | Protease 3C (Human rhinovirus) inhibitor | |||
| 0.065 | 0.007 | 0.065 | Peroxisome proliferator-activated receptor delta antagonist | |||
| 0.063 | 0.005 | 0.063 | Prostaglandin E2 agonist | |||
| 0.089 | 0.031 | 0.1 | Carbonic anhydrase inhibitor | 0.1 0.027 DBMET00584 | DBMET00584 | |
| 0.074 | 0.016 | 0.074 | Myc inhibitor | |||
| 0.063 | 0.005 | 0.063 | Leukotriene C4 antagonist | |||
| 0.062 | 0.005 | 0.062 | LFA antagonist | |||
| 0.062 | 0.005 | 0.062 | AMPA 3 receptor antagonist | |||
| 0.062 | 0.005 | 0.062 | NMDA receptor glycine site antagonist | |||
| 0.071 | 0.014 | 0.071 | Leukocyte elastase inhibitor | |||
| 0.061 | 0.005 | 0.061 | Carnitine palmitoyltransferase 1 inhibitor | |||
| 0.099 | 0.042 | 0.099 | Bromodomain-containing protein 2 inhibitor | |||
| 0.069 | 0.013 | 0.069 | Fructose-1,6-bisphosphatase inhibitor | |||
| 0.063 | 0.006 | 0.063 | Integrin alpha2 antagonist | |||
| 0.061 | 0.005 | 0.061 | ATP citrate lysase inhibitor | |||
| 0.075 | 0.02 | 0.075 | Calcium channel P-type blocker | |||
| 0.075 | 0.019 | 0.075 | Heme oxygenase stimulant | |||
| 0.131 | 0.076 | 0.131 | Bone formation stimulant | 0.121 0.084 DBMET00584 | ||
| 0.068 | 0.013 | 0.068 | Thymidylate synthase inhibitor | |||
| 0.067 | 0.013 | 0.067 | Sphingosine 1-phosphate receptor agonist | |||
| 0.158 | 0.105 | 0.238 | P-glycoprotein inhibitor | 0.238 0.045 DBMET00584 | DBMET00584 | |
| 0.088 | 0.034 | 0.088 | Epoxide hydrolase inhibitor | |||
| 0.149 | 0.096 | 0.642 | Nitric oxide antagonist | 0.642 0.008 DBMET00584 | DBMET00584 | |
| 0.094 | 0.041 | 0.094 | mTOR complex 2 inhibitor | |||
| 0.059 | 0.006 | 0.059 | Liver X receptor beta antagonist | |||
| 0.066 | 0.013 | 0.066 | Glutamate (mGluR1a) antagonist | |||
| 0.057 | 0.004 | 0.057 | Tryptophan 5 hydroxylase inhibitor | |||
| 0.163 | 0.11 | 0.163 | Focal adhesion kinase 2 inhibitor | |||
| 0.056 | 0.004 | 0.056 | Lysophosphatidic acid 1 receptor antagonist | |||
| 0.067 | 0.015 | 0.067 | Aldosterone antagonist | |||
| 0.07 | 0.018 | 0.07 | Sphingosine 1-phosphate receptor 1 antagonist | |||
| 0.057 | 0.005 | 0.057 | CF transmembrane conductance regulator antagonist | |||
| 0.066 | 0.014 | 0.066 | Adenylate cyclase 1 inhibitor | |||
| 0.077 | 0.026 | 0.077 | Carbonic anhydrase I inhibitor | 0.055 0.039 DBMET00584 | ||
| 0.053 | 0.003 | 0.053 | Nicotinic acid receptor 1 antagonist | |||
| 0.122 | 0.072 | 0.122 | Nav1.3 sodium channel blocker | |||
| 0.053 | 0.003 | 0.053 | Retinoid X gamma receptor antagonist | |||
| 0.077 | 0.027 | 0.077 | Collagenase 3 inhibitor | |||
| 0.113 | 0.062 | 0.113 | 5 Hydroxytryptamine 3A agonist | |||
| 0.067 | 0.017 | 0.121 | Glucose-6-phosphate translocase inhibitor | 0.121 0.004 DBMET00584 | DBMET00584 | |
| 0.074 | 0.024 | 0.074 | Phosphodiesterase 1C inhibitor | |||
| 0.057 | 0.007 | 0.057 | Lysophosphatidic acid 2 receptor antagonist | |||
| 0.073 | 0.023 | 0.073 | Fatty acid synthase inhibitor | 0.067 0.028 DBMET00584 | ||
| 0.053 | 0.004 | 0.053 | Prostaglandin H2 antagonist | |||
| 0.09 | 0.041 | 0.09 | Thioredoxin reductase inhibitor | |||
| 0.075 | 0.027 | 0.075 | Beta 3 adrenoreceptor antagonist | |||
| 0.066 | 0.018 | 0.066 | Prolyl endopeptidase inhibitor | 0.055 0.029 DBMET00584 | ||
| 0.059 | 0.011 | 0.059 | Glutamate (mGluR group II) antagonist | |||
| 0.052 | 0.004 | 0.052 | Calcium-independent phospholipase A2 inhibitor | |||
| 0.089 | 0.042 | 0.089 | CYP2A6 inhibitor | |||
| 0.05 | 0.003 | 0.055 | Vanilloid 2 agonist | 0.055 0.003 DBMET00584 | DBMET00584 | |
| 0.05 | 0.003 | 0.05 | Carbonic anhydrase VIII inhibitor | |||
| 0.05 | 0.003 | 0.05 | Carbonic anhydrase X inhibitor | |||
| 0.099 | 0.052 | 0.099 | Protein kinase C zeta inhibitor | |||
| 0.049 | 0.002 | 0.049 | Neuraminidase (Influenza B) inhibitor | 0.021 0.013 DBMET00584 | ||
| 0.106 | 0.06 | 0.21 | Toll-Like receptor 4 antagonist | 0.21 0.005 DBMET00584 | DBMET00584 | |
| 0.074 | 0.029 | 0.074 | Carbonic anhydrase stimulant | |||
| 0.066 | 0.021 | 0.066 | Nicotinic alpha3beta2 receptor antagonist | |||
| 0.073 | 0.028 | 0.1 | Carbonic anhydrase XII inhibitor | 0.1 0.02 DBMET00584 | DBMET00584 | |
| 0.073 | 0.028 | 0.073 | Androgen agonist | |||
| 0.063 | 0.018 | 0.063 | Carbonic anhydrase IV inhibitor | |||
| 0.049 | 0.005 | 0.049 | Protocollagen prolyl hydroxylase inhibitor | |||
| 0.052 | 0.008 | 0.052 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | |||
| 0.05 | 0.006 | 0.05 | Methionyl aminopeptidase 1 inhibitor | |||
| 0.058 | 0.014 | 0.058 | Liver X receptor alpha agonist | |||
| 0.049 | 0.006 | 0.049 | Epoxide hydrolase 1 inhibitor | |||
| 0.07 | 0.027 | 0.134 | Aldose reductase inhibitor | 0.134 0.012 DBMET00584 | DBMET00584 | |
| 0.056 | 0.013 | 0.056 | DNA gyrase subunit A inhibitor | |||
| 0.088 | 0.045 | 0.088 | Caspase 7 inhibitor | |||
| 0.047 | 0.005 | 0.047 | Integrin alpha2beta1 antagonist | |||
| 0.052 | 0.01 | 0.052 | AMPA 2 receptor antagonist | |||
| 0.051 | 0.01 | 0.051 | Factor XI inhibitor | |||
| 0.046 | 0.005 | 0.046 | Leukotriene B4 receptor 2 antagonist | 0.024 0.013 DBMET00584 | ||
| 0.049 | 0.008 | 0.049 | Peroxisome proliferator-activated receptor alpha antagonist | |||
| 0.117 | 0.076 | 0.117 | MAP kinase kinase inhibitor | |||
| 0.067 | 0.026 | 0.067 | Beta 2 adrenoreceptor agonist | |||
| 0.053 | 0.013 | 0.053 | Diamine oxidase inhibitor | |||
| 0.048 | 0.008 | 0.048 | Carnitine palmitoyltransferase 1A inhibitor | |||
| 0.045 | 0.005 | 0.045 | Protease (Human cytomegalovirus) inhibitor | |||
| 0.086 | 0.046 | 0.086 | CC chemokine 5 receptor agonist | |||
| 0.057 | 0.017 | 0.057 | Purinergic P2X4 antagonist | |||
| 0.071 | 0.032 | 0.08 | Carbonic anhydrase IX inhibitor | 0.08 0.027 DBMET00584 | DBMET00584 | |
| 0.049 | 0.01 | 0.049 | Angiotensin AT2 receptor antagonist | |||
| 0.069 | 0.03 | 0.069 | Carbonic anhydrase II inhibitor | 0.057 0.038 DBMET00584 | ||
| 0.106 | 0.067 | 0.158 | Multidrug resistance-associated protein 1 inhibitor | 0.158 0.022 DBMET00584 | DBMET00584 | |
| 0.041 | 0.002 | 0.041 | Glutamate (mGluR6) agonist | |||
| 0.043 | 0.005 | 0.043 | Lysophosphatidic acid receptor 1 agonist | |||
| 0.06 | 0.022 | 0.06 | Glutamate (mGluR group I) agonist | |||
| 0.043 | 0.006 | 0.043 | Protein kinase C beta I inhibitor | 0.043 0.006 DBMET00584 | ||
| 0.052 | 0.015 | 0.052 | Beta adrenoreceptor agonist | |||
| 0.048 | 0.011 | 0.048 | Purinergic P2Y2 antagonist | |||
| 0.046 | 0.009 | 0.046 | Cholesterol ester transfer protein antagonist | |||
| 0.047 | 0.01 | 0.047 | Leukotriene D4 antagonist | |||
| 0.083 | 0.047 | 0.083 | Nicotinic alpha4beta2 receptor antagonist | |||
| 0.052 | 0.015 | 0.052 | Alpha 1d adrenoreceptor agonist | |||
| 0.053 | 0.017 | 0.053 | Sphingosine 1-phosphate receptor 1 agonist | |||
| 0.046 | 0.009 | 0.046 | Prostaglandin D2 agonist | |||
| 0.234 | 0.199 | 0.234 | Transcription factor inhibitor | |||
| 0.083 | 0.048 | 0.083 | Somatostatin 1 agonist | |||
| 0.043 | 0.009 | 0.043 | Lysine carboxypeptidase inhibitor | |||
| 0.037 | 0.003 | 0.037 | Egl nine homolog 3 inhibitor | |||
| 0.056 | 0.023 | 0.056 | Oleamide hydrolase inhibitor | |||
| 0.061 | 0.028 | 0.061 | Epithelial sodium channel blocker | |||
| 0.037 | 0.004 | 0.037 | Egl nine homolog 1 inhibitor | |||
| 0.13 | 0.098 | 0.13 | Heat shock protein 90 antagonist | |||
| 0.062 | 0.029 | 0.062 | Sphingosine kinase 2 inhibitor | |||
| 0.076 | 0.044 | 0.076 | Potassium channel (Tandem pore domain) blocker | |||
| 0.042 | 0.011 | 0.042 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.031 0.017 DBMET00584 | ||
| 0.055 | 0.023 | 0.055 | Cholesterol esterase inhibitor | 0.052 0.026 DBMET00584 | ||
| 0.104 | 0.073 | 0.104 | GABA receptor agonist | |||
| 0.07 | 0.039 | 0.07 | Beta adrenoreceptor antagonist | |||
| 0.045 | 0.015 | 0.045 | Prostacyclin antagonist | |||
| 0.117 | 0.087 | 0.117 | Nav1.2 sodium channel blocker | |||
| 0.08 | 0.049 | 0.08 | Estrogen receptor alpha antagonist | |||
| 0.044 | 0.014 | 0.044 | Vanilloid 3 antagonist | |||
| 0.061 | 0.03 | 0.067 | Glucosylceramidase inhibitor | 0.067 0.024 DBMET00584 | DBMET00584 | |
| 0.037 | 0.007 | 0.037 | Estrogen-related receptor gamma antagonist | |||
| 0.066 | 0.037 | 0.066 | Transcription factor RelA inhibitor | |||
| 0.139 | 0.11 | 0.139 | LIM domain kinase 1 inhibitor | |||
| 0.044 | 0.015 | 0.044 | Peroxisome proliferator-activated receptor delta agonist | |||
| 0.03 | 0.001 | 0.03 | Mannitol 2-dehydrogenase inhibitor | |||
| 0.2 | 0.172 | 0.2 | Thioredoxin glutathione reductase inhibitor | |||
| 0.055 | 0.027 | 0.055 | Bombesin 2 receptor antagonist | |||
| 0.062 | 0.035 | 0.062 | Sphingosine kinase inhibitor | |||
| 0.039 | 0.012 | 0.039 | Protein kinase C beta II inhibitor | 0.033 0.021 DBMET00584 | ||
| 0.081 | 0.053 | 0.081 | Chymotrypsin inhibitor | |||
| 0.153 | 0.126 | 0.153 | Anticonvulsant | |||
| 0.041 | 0.014 | 0.041 | Liver X receptor beta agonist | |||
| 0.046 | 0.019 | 0.046 | Heme oxygenase inhibitor | |||
| 0.106 | 0.079 | 0.106 | Proteasome inhibitor | |||
| 0.086 | 0.059 | 0.086 | Androgen antagonist | |||
| 0.047 | 0.021 | 0.047 | Thymidine kinase inhibitor | 0.042 0.027 DBMET00584 | ||
| 0.038 | 0.012 | 0.038 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | |||
| 0.058 | 0.032 | 0.058 | Angiotensin-converting enzyme inhibitor | |||
| 0.03 | 0.004 | 0.03 | Angiotensin AT1B receptor antagonist | |||
| 0.032 | 0.006 | 0.032 | Complement factor 1s inhibitor | |||
| 0.028 | 0.003 | 0.028 | Methylmalonyl-CoA mutase inhibitor | 0.019 0.01 DBMET00584 | ||
| 0.06 | 0.035 | 0.06 | Beta 1 adrenoreceptor antagonist | |||
| 0.047 | 0.022 | 0.047 | Dihydrofolate reductase inhibitor | |||
| 0.061 | 0.036 | 0.061 | Botulinum neurotoxin type A inhibitor | |||
| 0.083 | 0.058 | 0.083 | Histamine H2 receptor antagonist | |||
| 0.114 | 0.089 | 0.114 | Glycogen synthase kinase-3 alpha inhibitor | |||
| 0.043 | 0.019 | 0.043 | DNA gyrase subunit B inhibitor | |||
| 0.03 | 0.006 | 0.03 | Aminopeptidase A inhibitor | |||
| 0.052 | 0.029 | 0.052 | HCV NS3/NS4A protease inhibitor | |||
| 0.116 | 0.094 | 0.116 | Cytokine production inhibitor | |||
| 0.026 | 0.004 | 0.026 | Human herpes virus 5 capsid protein P40 inhibitor | |||
| 0.03 | 0.009 | 0.03 | Prostaglandin F2 alpha agonist | |||
| 0.038 | 0.016 | 0.038 | Melatonin receptor 1A agonist | |||
| 0.029 | 0.007 | 0.029 | ICAM 1 antagonist | |||
| 0.034 | 0.012 | 0.034 | Kainate receptor 4 antagonist | |||
| 0.03 | 0.008 | 0.03 | Beta 1 adrenoreceptor agonist | |||
| 0.086 | 0.065 | 0.086 | Aminoacyl-tRNA synthetase inhibitor | |||
| 0.039 | 0.018 | 0.066 | Squalene synthetase inhibitor | 0.066 0.01 DBMET00584 | DBMET00584 | |
| 0.035 | 0.014 | 0.035 | Glutamate (mGluR2) antagonist | |||
| 0.081 | 0.06 | 0.081 | Inducible nitric-oxide synthase inhibitor | |||
| 0.087 | 0.067 | 0.127 | Thioredoxin inhibitor | 0.127 0.027 DBMET00584 | DBMET00584 | |
| 0.033 | 0.013 | 0.033 | Purinergic P2Y15 antagonist | |||
| 0.046 | 0.027 | 0.046 | Estradiol 17 beta-dehydrogenase inhibitor | |||
| 0.19 | 0.171 | 0.19 | Thyroid hormone antagonist | |||
| 0.024 | 0.004 | 0.024 | Lysophosphatidic acid receptor 3 agonist | |||
| 0.027 | 0.008 | 0.027 | Angiotensin AT1A receptor antagonist | |||
| 0.086 | 0.067 | 0.086 | Potassium channel activator | |||
| 0.034 | 0.016 | 0.034 | Diacylglycerol O-acyltransferase 1 inhibitor | |||
| 0.071 | 0.053 | 0.113 | Lipase inhibitor | 0.113 0.021 DBMET00584 | DBMET00584 | |
| 0.022 | 0.004 | 0.022 | Carbonic anhydrase XI inhibitor | |||
| 0.022 | 0.004 | 0.022 | Thrombopoietin agonist | |||
| 0.124 | 0.106 | 0.124 | MAP3K9 inhibitor | |||
| 0.025 | 0.007 | 0.025 | Kainate receptor 3 antagonist | |||
| 0.041 | 0.024 | 0.041 | Glucagon-like peptide 1 receptor antagonist | |||
| 0.023 | 0.005 | 0.023 | CXC chemokine 5 receptor antagonist | |||
| 0.059 | 0.042 | 0.059 | Bcl-xL inhibitor | |||
| 0.029 | 0.012 | 0.029 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.028 0.014 DBMET00584 | ||
| 0.047 | 0.03 | 0.047 | Glutamate (mGluR5) agonist | |||
| 0.027 | 0.01 | 0.027 | Fructose-1,6-bisphosphatase 1 inhibitor | |||
| 0.027 | 0.01 | 0.027 | Bombesin agonist | |||
| 0.03 | 0.013 | 0.03 | Hedgehog signaling activator | |||
| 0.035 | 0.019 | 0.035 | Carboxypeptidase B inhibitor | |||
| 0.026 | 0.009 | 0.026 | Isoleucine-tRNA ligase inhibitor | 0.022 0.017 DBMET00584 | ||
| 0.032 | 0.016 | 0.032 | Endothelin receptor antagonist | |||
| 0.021 | 0.005 | 0.021 | Thromboxane A2 agonist | |||
| 0.063 | 0.047 | 0.063 | Neutrophil collagenase inhibitor | |||
| 0.084 | 0.069 | 0.084 | Phosphodiesterase I inhibitor | |||
| 0.114 | 0.099 | 0.114 | Histone deacetylase SIRT1 inhibitor | |||
| 0.028 | 0.014 | 0.028 | Thymidine phosphorylase inhibitor | |||
| 0.023 | 0.009 | 0.023 | Bombesin 3 receptor agonist | |||
| 0.021 | 0.007 | 0.031 | Telomerase stimulant | 0.031 0.003 DBMET00584 | DBMET00584 | |
| 0.05 | 0.036 | 0.05 | Beta 2 adrenoreceptor antagonist | |||
| 0.022 | 0.008 | 0.022 | G-protein-coupled receptor 120 agonist | |||
| 0.022 | 0.008 | 0.045 | Antibiotic Anthracycline-like | 0.045 0.002 DBMET00584 | DBMET00584 | |
| 0.102 | 0.089 | 0.102 | Acetylcholine muscarinic antagonist | |||
| 0.05 | 0.037 | 0.05 | Potassium channel (Inward rectifier) activator | |||
| 0.075 | 0.062 | 0.075 | Histamine H1 receptor antagonist | |||
| 0.017 | 0.004 | 0.017 | Thromboxane agonist | |||
| 0.023 | 0.011 | 0.023 | Endothelin B receptor antagonist | |||
| 0.042 | 0.03 | 0.042 | Oxytocin agonist | |||
| 0.058 | 0.046 | 0.058 | Phosphodiesterase 1A inhibitor | |||
| 0.032 | 0.02 | 0.032 | Prostaglandin EP3 antagonist | |||
| 0.047 | 0.035 | 0.047 | Potassium channel (ATP-sensitive) activator | |||
| 0.121 | 0.11 | 0.351 | Anticoagulant | 0.351 0.021 DBMET00584 | DBMET00584 | |
| 0.102 | 0.091 | 0.102 | Calcium channel N-type blocker | |||
| 0.027 | 0.016 | 0.027 | Thyroid hormone agonist | |||
| 0.028 | 0.017 | 0.028 | CXC chemokine 2 receptor antagonist | |||
| 0.112 | 0.101 | 0.112 | Interleukin 1 antagonist | |||
| 0.05 | 0.04 | 0.05 | Ribonucleoside-diphosphate reductase inhibitor | |||
| 0.02 | 0.01 | 0.02 | Complement factor D inhibitor | |||
| 0.052 | 0.042 | 0.052 | CC chemokine 2 receptor antagonist | |||
| 0.045 | 0.035 | 0.052 | Antimetabolite | 0.052 0.03 DBMET00584 | DBMET00584 | |
| 0.021 | 0.011 | 0.021 | Caspase 8 inhibitor | |||
| 0.015 | 0.006 | 0.015 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | |||
| 0.03 | 0.021 | 0.03 | Elastase 3A inhibitor | |||
| 0.03 | 0.021 | 0.03 | Elastase 3B inhibitor | |||
| 0.03 | 0.021 | 0.03 | Elastase 2B inhibitor | |||
| 0.109 | 0.1 | 0.109 | Calcium channel blocker | |||
| 0.047 | 0.038 | 0.078 | Cytokine production stimulant | 0.078 0.005 DBMET00584 | DBMET00584 | |
| 0.051 | 0.042 | 0.051 | Ribonucleotide reductase inhibitor | |||
| 0.064 | 0.055 | 0.064 | Elastase 1 inhibitor | |||
| 0.033 | 0.025 | 0.033 | HCV polyprotein inhibitor | |||
| 0.029 | 0.02 | 0.029 | Liver X receptor alpha antagonist | |||
| 0.015 | 0.006 | 0.015 | Integrin beta2 antagonist | |||
| 0.068 | 0.059 | 0.068 | Nav1.8 sodium channel blocker | |||
| 0.042 | 0.034 | 0.042 | Histamine H1 receptor agonist | |||
| 0.035 | 0.027 | 0.045 | Ceramide glucosyltransferase inhibitor | 0.045 0.011 DBMET00584 | DBMET00584 | |
| 0.021 | 0.013 | 0.021 | Thymidine kinase (Herpes simplex virus 2) inhibitor | |||
| 0.019 | 0.012 | 0.019 | Estrogen-related receptor gamma agonist | |||
| 0.055 | 0.048 | 0.055 | Heat shock protein 90 beta antagonist | |||
| 0.045 | 0.038 | 0.045 | Benzodiazepine antagonist | |||
| 0.031 | 0.024 | 0.031 | Dipeptidyl peptidase II inhibitor | |||
| 0.029 | 0.023 | 0.029 | Liver X receptor antagonist | |||
| 0.058 | 0.052 | 0.058 | Trypsin inhibitor | |||
| 0.03 | 0.024 | 0.03 | Estradiol 17 beta-dehydrogenase 3 inhibitor | |||
| 0.025 | 0.02 | 0.109 | Sodium/glucose cotransporter 2 inhibitor | 0.109 0.003 DBMET00584 | DBMET00584 | |
| 0.098 | 0.092 | 0.207 | Beta amyloid protein antagonist | 0.207 0.015 DBMET00584 | DBMET00584 | |
| 0.037 | 0.032 | 0.045 | Toll-Like receptor 2 agonist | 0.045 0.026 DBMET00584 | DBMET00584 | |
| 0.057 | 0.051 | 0.057 | Enoyl-[acyl-carrier-protein] reductase inhibitor | |||
| 0.057 | 0.051 | 0.063 | Transcription factor AP-1 inhibitor | 0.063 0.039 DBMET00584 | DBMET00584 | |
| 0.043 | 0.038 | 0.043 | Potassium channel Kv1.3 blocker | |||
| 0.068 | 0.062 | 0.068 | Adenosine A3 receptor antagonist | |||
| 0.019 | 0.014 | 0.019 | Guanylate cyclase 1 stimulant | |||
| 0.042 | 0.038 | 0.071 | Microtubule stabilization | 0.071 0.006 DBMET00584 | DBMET00584 | |
| 0.008 | 0.003 | 0.008 | Insulin like growth factor 3 antagonist | |||
| 0.055 | 0.05 | 0.075 | Lipocortins synthesis agonist | 0.075 0.017 DBMET00584 | DBMET00584 | |
| 0.033 | 0.029 | 0.033 | AMPA receptor agonist | |||
| 0.016 | 0.013 | 0.034 | Ileal bile acid transport inhibitor | 0.034 0.004 DBMET00584 | DBMET00584 | |
| 0.07 | 0.066 | 0.07 | Metalloproteinase-2 inhibitor | |||
| 0.008 | 0.005 | 0.008 | DNA topoisomerase III inhibitor | |||
| 0.082 | 0.079 | 0.082 | Polo-like kinase-1 inhibitor | |||
| 0.028 | 0.025 | 0.028 | DNA topoisomerase IV inhibitor | |||
| 0.012 | 0.009 | 0.012 | Egl nine homolog 2 inhibitor | |||
| 0.024 | 0.021 | 0.106 | Sodium/glucose cotransporter inhibitor | 0.106 0.003 DBMET00584 | DBMET00584 | |
| 0.014 | 0.011 | 0.014 | N-Acetylated alpha-linked acidic dipeptidase inhibitor | |||
| 0.059 | 0.057 | 0.059 | Acetylcholine M5 receptor agonist | |||
| 0.054 | 0.052 | 0.054 | TRPA1 antagonist | |||
| 0.019 | 0.017 | 0.019 | Endothelin A receptor antagonist | |||
| 0.02 | 0.018 | 0.02 | Geranylgeranyltransferase inhibitor | |||
| 0.006 | 0.005 | 0.006 | Integrin alpha5beta6 antagonist | |||
| 0.011 | 0.009 | 0.011 | CD80 antagonist | |||
| 0.016 | 0.014 | 0.016 | CC chemokine 9 receptor antagonist | |||
| 0.054 | 0.052 | 0.054 | Phosphodiesterase 1B inhibitor | |||
| 0.014 | 0.013 | 0.014 | Purinergic P2Y1 agonist | |||
| 0.056 | 0.055 | 0.095 | Nitric oxide donor | 0.095 0.011 DBMET00584 | DBMET00584 | |
| 0.01 | 0.009 | 0.01 | Beta 3 adrenoreceptor agonist | |||
| 0.029 | 0.028 | 0.029 | Calcitonin receptor agonist | |||
| 0.008 | 0.011 | 0.014 | Purinergic P2Y2 agonist | 0.014 0.004 DBMET00584 | DBMET00584 | |
| 0.02 | 0.023 | 0.021 | Vitamin D receptor antagonist | 0.021 0.018 DBMET00584 | DBMET00584 | |
| 0.077 | 0.082 | 0.08 | Protein kinase C delta inhibitor | 0.08 0.076 DBMET00584 | DBMET00584 | |
| 0.066 | 0.072 | 0.08 | Phosphodiesterase VI inhibitor | 0.08 0.041 DBMET00584 | DBMET00584 | |
| 0.184 | 0.196 | 0.485 | Caspase 3 stimulant | 0.485 0.023 DBMET00584 | DBMET00584 | |
| 0.054 | 0.085 | 0.212 | Topoisomerase II alpha inhibitor | 0.212 0.013 DBMET00584 | DBMET00584 | |
| 0.011 | 0.05 | 0.027 | Corticosteroid-like | 0.027 0.009 DBMET00584 | DBMET00584 | |
| 0.069 | 0.11 | 0.124 | ATPase (Vacuolar H+) inhibitor | 0.124 0.017 DBMET00584 | DBMET00584 | |
| 0.058 | 0.123 | 0.342 | Topoisomerase I inhibitor | 0.342 0.008 DBMET00584 | DBMET00584 | |
| 0.017 | 0.087 | 0.059 | Estrogen agonist | 0.059 0.031 DBMET00584 | DBMET00584 | |
| 0.002 | 0.075 | 0.019 | Antibiotic Macrolide-like | 0.019 0.007 DBMET00584 | DBMET00584 | |
| 0.033 | 0.116 | 0.268 | Antineoplastic antibiotic | 0.268 0.012 DBMET00584 | DBMET00584 | |
| 0.003 | 0.086 | 0.013 | Purinergic receptor agonist | 0.013 0.012 DBMET00584 | DBMET00584 | |
| 0.003 | 0.086 | 0.013 | Purinergic P2 agonist | 0.013 0.012 DBMET00584 | DBMET00584 | |
| 0.039 | 0.123 | 0.063 | Protein kinase C alpha inhibitor | 0.063 0.055 DBMET00584 | DBMET00584 | |
| 0.023 | 0.118 | 0.142 | Protein 50S ribosomal subunit inhibitor | 0.142 0.007 DBMET00584 | DBMET00584 | |
| 0.04 | 0.137 | 0.122 | Histone deacetylase stimulant | 0.122 0.017 DBMET00584 | DBMET00584 | |
| 0.04 | 0.137 | 0.122 | Histone deacetylase SIRT1 stimulant | 0.122 0.017 DBMET00584 | DBMET00584 | |
| 0.083 | 0.187 | 0.168 | Amyloid beta aggregation inhibitor | 0.168 0.096 DBMET00584 | DBMET00584 | |
| 0.011 | 0.135 | 0.03 | 1,3-Beta-glucan synthase inhibitor | 0.03 0.015 DBMET00584 | DBMET00584 | |
| 0.006 | 0.137 | 0.014 | S-adenosyl-L-homocysteine hydrolase inhibitor | 0.014 0.011 DBMET00584 | DBMET00584 | |
| 0.144 | 0.284 | 0.247 | Antiobesity | 0.247 0.16 DBMET00584 | DBMET00584 | |
| 0.019 | 0.162 | 0.092 | Antibiotic Aminoglycoside-like | 0.092 0.003 DBMET00584 | DBMET00584 | |
| 0.035 | 0.183 | 0.139 | Protein kinase A inhibitor | 0.139 0.027 DBMET00584 | DBMET00584 | |
| 0.007 | 0.171 | 0.019 | O6-alkylguanine-DNA alkyltransferase inhibitor | 0.019 0.008 DBMET00584 | DBMET00584 | |
| 0.108 | 0.334 | 0.599 | Immunomodulator | 0.599 0.012 DBMET00584 | DBMET00584 | |
| 0.014 | 0.241 | 0.041 | Toll-Like receptor 4 agonist | 0.041 0.005 DBMET00584 | DBMET00584 | |
| 0.008 | 0.247 | 0.074 | Protein 30S ribosomal subunit inhibitor | 0.074 0.004 DBMET00584 | DBMET00584 | |
| 0.027 | 0.312 | 0.137 | DNA intercalator | 0.137 0.049 DBMET00584 | DBMET00584 | |
| 0.055 | 0.37 | 0.154 | Interleukin 6 antagonist | 0.154 0.082 DBMET00584 | DBMET00584 | |
| 0.021 | 0.406 | 0.11 | Protein kinase C mu inhibitor | 0.11 0.048 DBMET00584 | DBMET00584 | |
| 0.041 | 0.464 | 0.568 | Tumour necrosis factor alpha release inhibitor | 0.568 0.009 DBMET00584 | DBMET00584 | |
| 0.03 | 0.621 | 0.307 | Angiogenesis inhibitor | 0.307 0.089 DBMET00584 | DBMET00584 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |